The potential of subanesthetic intravenous ketamine as an effective and non-inferior alternative to electroconvulsive therapy (ECT) for treating non-psychotic, treatment-resistant depression has been unveiled by a groundbreaking study led by researchers from Mass General Brigham. Published in the prestigious New England Journal of Medicine, the study’s findings offer hope for individuals grappling with severe depression… Read More »
Antidepressants may Build Resistance Against Antibiotics in Bacteria
focuses on bacterial exposure of five of the most common antidepressants prescribed in Australia. The antidepressants looked at in this study are sertraline (Zoloft), escitalopram (Lexapro), bupropion (Welbutrin), duloxetine (Cymbalta), and agomelatine (Valdoxan). Advertisement Using the E. coli K-12 strain MG1655 – a typical bacterial strain known to be responsive to antibiotics – the team… Read More »
